Psychiatry Research: Neuroimaging
Volume 155, Issue 1 , Pages 11-19 , 15 May 2007

Fronto-temporal-lobe atrophy in early-stage Alzheimer's disease identified using an improved detection methodology

  • Tom F.D. Farrow

      Affiliations

    • Sheffield Cognition and Neuroimaging Laboratory (SCANLab), Academic Clinical Psychiatry, University of Sheffield, The Longley Centre, Northern General Hospital, Norwood Grange Drive, Sheffield S5 7JT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 114 226 1511; fax: +44 114 226 1522.
    • ,
  • Subha N. Thiyagesh

      Affiliations

    • Sheffield Cognition and Neuroimaging Laboratory (SCANLab), Academic Clinical Psychiatry, University of Sheffield, The Longley Centre, Northern General Hospital, Norwood Grange Drive, Sheffield S5 7JT, UK
    • ,
  • Iain D. Wilkinson

      Affiliations

    • Academic Unit of Radiology, University of Sheffield, UK
    • ,
  • Randolph W. Parks

      Affiliations

    • Sheffield Cognition and Neuroimaging Laboratory (SCANLab), Academic Clinical Psychiatry, University of Sheffield, The Longley Centre, Northern General Hospital, Norwood Grange Drive, Sheffield S5 7JT, UK
    • ,
  • Leanne Ingram

      Affiliations

    • Sheffield Cognition and Neuroimaging Laboratory (SCANLab), Academic Clinical Psychiatry, University of Sheffield, The Longley Centre, Northern General Hospital, Norwood Grange Drive, Sheffield S5 7JT, UK
    • ,
  • Peter W.R. Woodruff

      Affiliations

    • Sheffield Cognition and Neuroimaging Laboratory (SCANLab), Academic Clinical Psychiatry, University of Sheffield, The Longley Centre, Northern General Hospital, Norwood Grange Drive, Sheffield S5 7JT, UK

Received 12 May 2006 ,Revised 12 December 2006 ,Accepted 26 December 2006.

References 

  1. Ashburner J, Friston KJ. Voxel based morphometry — the methods. NeuroImage. 2000;1:805–821
  2. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, et al. In vivo mapping of gray matter loss in voxel-based morphometry in mild Alzheimer's disease. NeuroImage. 2001;14:298–309
  3. Basso M, Yang J, Warren L, MacAvoy MG, Varma P, Bronen RA, et al. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Research. Neuroimaging. 2006;146:251–261
  4. Bigler ED, Neeley ES, Miller MJ, Tate DF, Rice SA, Cleavinger H, et al. Cerebral volume loss, cognitive deficit and neuropsychological performance: comparative measures of brain atrophy: I. Dementia. Journal of the International Neuropsychological Society. 2004;10:442–452
  5. Boxer AL, Kramer JH, Du A-T, Schuff N, Weiner MW, Miller BL, et al. Focal right inferotemporal atrophy in AD with disproportionate visual constructive impairment. Neurology. 2003;61:1485–1491
  6. Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiology of Aging. 2003;24:221–231
  7. Critchley HD, Mathias CJ, Dolan RJ. Fear conditioning in humans: the influence of awareness and autonomic arousal on functional neuroanatomy. Neuron. 2002;33:656–663
  8. De Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. American Journal of Neuroradiology. 1993;14:897–906
  9. Farrow TFD, Hunter MD, Wilkinson ID, Green RDJ, Spence SA. The structural brain correlates of unconstrained motor activity in people with schizophrenia. British Journal of Psychiatry. 2005;187:481–482
  10. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12:189–198
  11. Good CD, Johnsrude I, Ashburner J, Henson RNA, Friston KJ, Frackowiak RSJ. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage. 2001;14:21–36
  12. Haralick RM, Sternberg SR, Zhuang X. Image analysis using mathematical morphology. IEEE Transactions on Pattern Analysis and Machine Intelligence. 1987;9:532–550
  13. Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?. American Journal of Psychiatry. 2005;162:676–682
  14. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P, et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. NeuroImage. 2003;18:895–907
  15. Karas GB, Scheltens P, Rombouts SARB, Visser PJ, van Schijndel RA, Fox NC, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. NeuroImage. 2004;23:708–716
  16. Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C, et al. Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biological Psychiatry. 2000;47:1056–1063
  17. Maldjian JA, Laurienti PJ, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19:1233–1239
  18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  19. Pantel J, Schönknecht P, Essig M, Schröder J. Distribution of cerebral atrophy assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia. Neuroscience Letters. 2004;361:17–20
  20. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiology of Aging. 2004;25:303–310
  21. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. American Journal of Psychiatry. 1986;141:1356–1364
  22. Talairach J, Tournoux P. Co-planar Stereotactic Atlas of the Human Brain. Stuttgart: Thieme-Verlag; 1988;
  23. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, et al. Dynamics of gray matter loss in Alzheimer's disease. The Journal of Neuroscience. 2003;23:994–1005
  24. Zahn R, Buechert M, Overmans J, Talazko J, Specht K, Ko C-W, et al. Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography. Psychiatry Research. Neuroimaging. 2005;140:115–131
  25. Zakzanis KK, Graham SJ, Campbell Z. A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile. NeuroImage. 2004;23:708–716
  26. Zamrini E, De Santi S, Tolar M. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Neurobiology of Aging. 2004;25:685–691
  27. Zec RF. Neuropsychological functioning in Alzheimer's disease. In:  Parks RW,  Zec RF,  Wilson RS editor. Neuropsychology of Alzheimer's Disease and Other Dementias. New York: Oxford University Press; 1993;p. 3–80

PII: S0925-4927(07)00007-8

doi: 10.1016/j.pscychresns.2006.12.013

Psychiatry Research: Neuroimaging
Volume 155, Issue 1 , Pages 11-19 , 15 May 2007

Article Tools

* Image Usage & Resolution